CBA Informatique is a leading French Saas software vendor, dedicated to health and social care industries, providing liberal medical professionals with feature-rich and fully digital information systems.
The company was founded in 1986 in Avignon, France, in the context of a nascent market, which allowed CBA to seize substantial market share and quickly reach a leading position on its core market.
The company continually expanded its footprint and customer base since inception and serves more than 25,000 customers to date.
CBA generates revenue of +EUR20 million mostly made of recurring and highly profitable contracts.
The investment from Five Arrows Principal Investment in the company will allow for further expansion of the business, both organically and through targeted acquisition.
Five Arrows Principal Investments (FAPI) is the European corporate private equity business of Rothschild Merchant Banking. Based in London, Paris and Luxembourg, FAPI investment professionals manage €1.4 billion of capital focused on investing in lower middle-market companies in Western Europe. They are currently investing from Five Arrows Principal Investments II, a €781 million fund closed in October 2015. Their first fund, Five Arrows Principal Investments I, which launched in 2010, gathered €583 million of commitments and is now fully invested and in the process of being realised.
Bryan, Garnier & Co acted as the Sole Financial Advisor to Five Arrows on their equity investment in CBA Informatique.
Bryan, Garnier & Co assisted Five Arrows in approaching the target, organizing the due diligence, providing sector and process intelligence and negotiating the transaction with the shareholders of CBA Informatique.
This marks another landmark transaction for Bryan Garnier’s recent software deals including the sale of Regas to Bid Equity, the sale of Impeo to Riverside’s portfolio company Fadata, the sale of Picturae to Karmijn, the sale of Prima Solutions to The Carlyle Group, the sale of Allegorithmic to Adobe and the sale of Eudonet to Quilvest.